Talk:Overmedication
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Text and/or other creative content from this version of Overprescription was copied or moved into Overmedication with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
Wiki Education Foundation-supported course assignment edit
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Bking22. Peer reviewers: Jammer092.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 05:57, 17 January 2022 (UTC)
APAP edit
The article confuses acute overdose, intoxication, and prolonged overdose (overmedication), with the result that it's inaccurate and useless. Full rewrite needed.JohnChrysostom (talk) 11:35, 10 December 2011 (UTC)
Drug synergy edit
It should be made clearer than some interactions of medications are intentional (Drug synergy) by the medical practitioner. A example would be adding a CNS stimulant to a opioid analgesic to offset the effects of sedation and increase effectiveness of pain relief.
The article should be rewritten with verifiable sources.
Matthewburmeister (talk) 10:08, 5 April 2012 (UTC)
Effects section edit
The effects section lists unnecessary or useless information about side effects and could scare or give the reader a wrong impression. So i went bold and removed it. Matthewburmeister (talk) 10:44, 5 April 2012 (UTC)
Exploring Alternatives to Mood-Altering Drugs in Children edit
Children who show behavior like rage, aggressive attacks, psychosis, frequent volatility, and assaultive behavior are in need of treatment (Sathpathy). Treatments that help mental disorders include therapy, most of the time before medications. There are many factors that could potentially harm the anti-psychotic medicated children such as social problems among peers and family, physical issues, and irregular cognitive development. Understanding the adverse effects of anti-psychotic drugs when consumed by teenagers is an important study that was conducted in France a couple years ago. The study found many problems that were produced from the anti-psychotic drug Risperidone which treats schizophrenia, bipolar disorder and irritability. Many of the Risperidone treated adolescents gained a significant amount of weight, developed movement disorders, became agitated and restless, and developed muscle weakness. A small amount of the group were lethargic and constantly slept, one patient had such an adverse effect that they were hospitalized (Menard, et al.). Prescribing anti-psychotic drugs to children and teens who exhibit disruptive behavior has become more frequent, but there is very little research on the long term effects that these children will experience. The brain is not fully developed until the age of twenty-five, so it is reasonable to have concern that drugs like anti psychotics could affect development of the brain in children. Therapy can help with a myriad of issues that children may have, whether they are behavioral or trauma related. Art therapy is a very effective approach when treating children. For children to trust a therapist, they need to feel like the therapist knows and understands their feelings, and art therapy acts as a wonderful catalyst in achieving trust. Every situation varies from child to child; they may need drugs, they may require therapy, or they may need to be in a healthier environment. Parents and doctors need to consider alternative methods before resorting to prescribing mood-altering drugs to children and adolescents in order to avoid proven health complications, developmental issues, and social hardships.
Works Cited [1] [2] [3] [4] [5] [6] [7] — Preceding unsigned comment added by Maryelizabethgray (talk • contribs) 01:36, 21 April 2016 (UTC)
References
- ^ Charach, Alice, Emanuela Yeung, Tiziana Volpe, Tara Goodale, and Susan Reis. “Exploring Stimulant Treatment in ADHD: Narratives of Young Adolescents and their Parents.” BMC Psychiatry, 14.1 (2014): 1-20. Web. 10 April 2016. <http://web.b.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=99f97c37-fa07-4c4d-bccc-39a4546dfc2e%40sessionmgr120&vid=13&hid=109>
- ^ Kuban, Caelan. “Healing Trauma through Art.” Reclaiming Children & Youth 24.2 (2015): 18-20. Web. 9 April 2016. <http://web.b.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=b0a613ac-0773-47f6-bb60-b8a37f9d0466%40sessionmgr110&vid=5&hid=109>
- ^ Liashko, Vitaly, and Katharina Manassis. “Medicated Anxious Children: Characteristics and Cognitive-Behavioural Treatment Response.” Canadian Journal of Psychiatry 48.11 (2003): 741-748. Web. 10 April 2016. <http://web.b.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=99f97c37-fa07-4c4d-bccc-39a4546dfc2e%40sessionmgr120&vid=6&hid=109>
- ^ McKinney, Cliff, and Kimberly Renk. “Atypical Antipsychotic Medications in the Management of Disruptive Behaviors in Children: Safety Guidelines and Recommendations.” Clinical Psychology Review 31.3 (2011): 465-471. Web. 30 Mar. 2016. <http://web.b.ebscohost.com/ehost/detail/detail?vid=21&sid=7d99e641-5531-495d-8c97-6a4b71f0d110%40sessionmgr110&hid=116&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d%3d#AN=59186382&db=a9h>
- ^ Menard, Marie-Line, Susanne Thümmler, Philippe Auby, and Florence Askenazy. “Preliminary and Ongoing French Multicenter Prospective Naturalistic Study of Adverse Events of Antipsychotic Treatment in Naive Children and Adolescents.” Child & Adolescent Psychiatry & Mental Health 8.1 (2014): 2-14. Web. 30 Mar. 2016. <http://web.b.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=7d99e641-5531-495d-8c97-6a4b71f0d110%40sessionmgr110&vid=10&hid=116>
- ^ Rani Fariz A., Patrick Byrne, Noel Cranswick, Macey L. Murray, and Ian C.K. Wong. “Mortality in Children and Adolescents Prescribed Antipsychotic Medication.” Drug Safety 34.9 (2011): 773-781. Web. 9 Mar. 2016. <http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=089b91b8-da81-436a-8bde-3da2a4b0e45e%40sessionmgr4004&vid=4&hid=4114>
- ^ Sathpathy, S., and B. Winsberg. “Extrapyramidal Symptoms in Two Children Taking Atypical Antipsychotics.” Brown University Child & Adolescent Psychopharmacology Update, 6.1 (2004): 8-8. Web. 10 April 2016. < http://web.b.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=99f97c37-fa07-4c4d-bccc-39a4546dfc2e%40sessionmgr120&vid=16&hid=109>
- @Maryelizabethgray: Please keep in mind that sources cited in this article should follow the guidelines for reliable sources in medical articles. At least two of the articles cited above don't meet these criteria:
- Menard, et al. 2014: Primary research.
- Sathpathy & Winsberg 2004: Case studies.
- Also, because session-based links (like those above) are time-limited and user-specific, readers and other editors cannot use them to access articles. Please use DOIs, permalinks, or similar permanent identifiers for links in citations. —Shelley V. Adams ‹blame
credit› 00:19, 7 August 2016 (UTC)
Elderly edit
I went looking for sources related to overmedication and found that many google results are focusing on this phenomenom in elderly people. When this article is rewritten, this should be given a substantial section, rather than the current focus, which appears to be pediatric psychotropics. Natureium (talk) 02:14, 10 October 2018 (UTC)
- This article does not address many marginalized populations that overmedication affects, especially seniors. This section should be just as important as the paediatrics section, as seniors are not prioritized as much when talking about topics like this.Sahrishmasood (talk) 23:27, 3 October 2020 (UTC)